H1N1 | H3N2 | B | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SEROPROTECTION | No. studies | No. patients | Overall RR (95 % CI)a | Heterogeneity test (p; I2%) | No. studies | No. patients | Overall RR (95 % CI)a | Heterogeneity test (p; I2%) | No. studies | No. patients | Overall RR (95 % CI)a | Heterogeneity test (p; I2%) |
All studies | 6 | 673 | 1.00 (0.91-1.1) | 0.272;21.5 | 6 | 673 | 1.00 (0.9-1.12) | 0.042;56.6 | 6 | 673 | 0.99 (0.84-1.16) | 0.072;50.5 |
High qualityb | 5 | 566 | 1.01 (0.86-1.18) | 0.177; 36.7 | 5 | 566 | 1.02 (0.88-1.19) | 0.05;57.9 | 5 | 566 | 0.98 (0.79-1.22) | 0.041;59.8 |
Low qualityb | 1 | 107 | 1.02 (0.94-1.11) | - | 1 | 107 | 0.98 (0.92-1.05) | - | 1 | 107 | 0.94 (0.79-1.16) | - |
Antigen content ≥12 μg | 3 | 358 | 1.13 (0.9-1.43) | 0.248;28.4 | 3 | 358 | 1.03 (0.77-1.39) | 0.01;78.4 | 3 | 358 | 0.94 (0.61-1.47) | 0.01;78.1 |
Antigen content ≤ 9 μg | 3 | 315 | 0.95 (0.8-1.14) | 0.067;63 | 3 | 315 | 0.99 (0.93-1.05) | 0.368;0.1 | 3 | 315 | 0.96 (0.84-1.09) | 0.935;0 |
One injection | 4 | 377 | 0.99 (0.86-1.15) | 0.136;45.9 | 4 | 377 | 1.04 (0.9-1.2) | 0.087;54. 3 | 4 | 377 | 0.98 (0.87-1.11) | 0.783;0 |
Two injections | 2 | 296 | 1.05 (0.84-1.3) | 0.291;10.2 | 2 | 296 | 0.96 (0.72-1.29) | 0.015;83.1 | 2 | 296 | 0.8 (0.34-1.99) | 0.003;88.8 |
Mantoux technique | 2 | 263 | 0.93 (0.71-1.24) | 0.012;84 | 2 | 263 | 1.00 (0.89-1.13) | 0.177;45.2 | 2 | 263 | 0.95 (0.82-1.1) | 0.819;0 |
Micro injection system | 4 | 410 | 1.06 (0.92-1.22) | 0.378;2.9 | 4 | 410 | 1.02 (0.83-1.26) | 0.027;67.4 | 4 | 410 | 0.98 (0.73-1.32) | 0.027;67.4 |
Cause of immunosuppression: | ||||||||||||
Transplantation | 4 | 344 | 1.11 (0.86-1.43) | 0.228;30.7 | 4 | 344 | 1.04 (0.8-1.35) | 0.22;68.9 | 4 | 344 | 0.91 (0.61-1.36) | 0.018;70.2 |
Other diseasesb | 3 | 488 | 0.98 (0.87-1.1) | 0.216;34.7 | 3 | 488 | 0.99 (0.93-1.05) | 0.465;0 | 4 | 488 | 0.97 (0.86-1.1) | 0.98;0 |
SEROCONVERSION | ||||||||||||
All studies | 5 | 517 | 1.00 (0.84-1.19) | 0.532;0 | 5 | 517 | 1.08 (0.86-1.36) | 0.569;0 | 5 | 517 | 0.92 (0.72-1.17) | 0.578;0 |
High qualityb | 4 | 410 | 1.04 (0.79-1.36) | 0.399; 0 | 4 | 410 | 1.00 (0.75-1.34) | 0.52;0 | 4 | 410 | 1.13 (0.77-1.66) | 0.823;0 |
Low qualityb | 1 | 107 | 0.98 (0.78-1.23) | - | 1 | 107 | 1.23 (0.83-1.83) | - | 1 | 107 | 0.80 (0.59-1.09) | - |
Antigen content ≥12 μg | 3 | 358 | 1.17 (0.85-1.62) | 0.545;0 | 3 | 358 | 1.06 (0.73-1.55) | 0.36;2 | 3 | 358 | 1.11 (0.7-1.75) | 0.641;0 |
Antigen content ≤ 9 μg | 2 | 159 | 0.95 (0.77-1.16) | 0.443;0 | 2 | 159 | 1.1 (0.81-1.45) | 0.35;0 | 2 | 159 | 0.85 (0.64-1.13) | 0.33;0 |
One injection | 3 | 221 | 0.99 (0.74-1.34) | 0.242;29.6 | 3 | 221 | 1.16 (0.86-1.57) | 0.341;7 | 3 | 221 | 0.86 (0.65-1.13) | 0.589;0 |
Two injections | 2 | 296 | 1.09 (0.77-1.55) | 0.961;0 | 2 | 296 | 0.94 (0.63-1.4) | 0.735;0 | 2 | 296 | 1.14 (0.68-1.9) | 0.359;0 |
Mantoux technique | 1 | 107 | 0.98 (0.78-1.23) | - | 1 | 107 | 1.23 (0.83-1.83) | - | 1 | 107 | 0.80 (0.59-1.09) | - |
Micro injection system | 4 | 410 | 1.04 (0.79-1.36) | 0.399; 0 | 4 | 410 | 1.00 (0.75-1.34) | 0.52;0 | 4 | 410 | 1.13 (0.77-1.66) | 0.823;0 |
Cause of immunosuppression: | ||||||||||||
Transplantation | 3 | 358 | 1.17 (0.85-1.62) | 0.545;0 | 3 | 358 | 1.06 (0.73-1.55) | 0.36;2 | 3 | 358 | 1.11 (0.7-1.75) | 0.641;0 |
Other diseasesc | 2 | 159 | 0.95 (0.77-1.16) | 0.443;0 | 2 | 159 | 1.1 (0.81-1.45) | 0.35;0 | 2 | 159 | 0.85 (0.64-1.13) | 0.33;0 |